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Primary biliary cirrhosis
A retrospective survey at Groote Schuu! Hospital, Cape Town
S. C. ROBSON, R. J. HIFT, R. E. KIRSCH
~ummary
Primary biliary cirrhosis (PBC) or chronic non-suppura.tive
destructive cholangiohepatitis is rare in southern Afnca. Eight
patients with this diagnosis were identified and fully investi-
gated at Groote Schuur Hospital betwe.en 1980 and 1988.
Seven patients were female, all were white or coloured, and
their ages ranged from 49 years to 80 years. All patients
presented with a history of malaise, fatigue, night sweats and
pruritus, which had been present for 3 months - 12 yea~s
before diagnosis of PBC. Initial misdiagnosis had resulted In
unnecessary invasive investigations including laparot~mies.
Signs of chronic liver disease, such as xantholasmas, eVidence
of pruritus, the sicca syndrome or hepatomegaly, were invari-
ably present. Marked elevation of serum alkaline phosphatase
level and IgM were present in all cases. Antimitochondrial
antibodies were positive in significant titre in 7 of the 8
patients. Liver biopsies demonstrated stage 11-11I disease in
all patients. Therapy was chiefly supportive and symptomatic
although most patients received immunosuppressive agents.
Despite the late presentation, the subsequent. course was
similar to that seen elsewhere where patients are recognised
earlier.
S Air Med J 1990; 78: 19-:!?
Primary biliary cirrhosis (pBC), more accurately termed chronic
non-suppurative destructive cholangiohepatitis, is a chronic,
progressive, cholestatic form of liver disease, which charac-
teristically has a long duration of symptoms and ultimately
evolves into cirrhosis and liver failure. 1 The condition has
been found in all races, with estimates of its prevalence
ranging from 3,7 cases/lOOOOO to 14,4 cases/lOOOOO.2 Our
perception is that this condition is uncommon in southern
Mrica. This is in contrast to the higher incidence than else-
where of sclerosing cholangitis, sarcoidosis and drug-induced
cholestasis: which cause a similar derangement of liver function.
The diagnosis of PBC is usually made in a middle-aged
woman complaining of fatigue and pruritus, or following
investigation for unexplained hepatomegaly or raised serum
alkaline phosphatase levels. Laboratory testing reveals
immunological abnormalities, including impaired in vitro sup-
pressor T -cell function, high levels of serum IgM and the
presence of antirnitochondrial antibodies.3 The condition is
characterised on histological examination of tissue specimens
by the destruction of intrahepatic bile ducts, portal inflltration
and parenchymal scarring.4 .
Eight patients with PBC were seen at Groote Schuur Hos-
pital between 1980 and 1988. This group is described in the
hope that our experience may lead others to make an earlier
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diagnosis in patients with this syndrome, thus preventing
unnecessary invasive investigations, such as diagnostic laparo-
tomy.
Patients and methods
All patients seen for the first time or followed up at the Groote
Schuur Hospital liver clinic from 1980 to 1988 were reviewed.
These patients were referred by general practitioners and
specialists and therefore represented a mixture of secondary
and tertiary referrals. Although the majority of our patients
are referred from the Cape Town area, about 10-15% of
referrals are from elsewhere in South Mrica. Approximately
100 new and 500 'follow-up' patients are seen at the clinic
each year.
The diagnosis of PBC was suspected on the basis of com-
patible clinical and biochemical findings and was confirmed by
the detection of antimitochondrial antibodies (in most cases),
exciusion of bile duct obstruction by ultrasonography and
endoscopic retrograde cholangiopancreatography, and by liver
biopsy. PBC was staged on the basis of histological examination
only. Patients have been followed up for 1- 8 years.
Results
During the period 1980 - 1988, 8 patients met the criteria for
the diagnosis of PBC; 7 were women, 5 white and 3 coloured
(mixed race). Their ages, at diagnosis, ranged from 49 years to
80 years.
Clinical manifestations
Symptoms had been present for up to 12 years in the 8
patients before they were referred to our clinic and primary
biliary cirrhosis was diagnosed. These ·symptoms included
fever, fatigue, malaise, night sweats, pruritus, arthritis and
myalgias. The clinical presentations were highly variable. Two
patients were initially seen by dermatologists for pruritus (Fig.
1). One patient was referred to an orthopaedic surgeon with
multiple vertebral wedge fractures (Fig. 2). Two pa,tients
presented with a systemic illness marked by intermittent
pyrexia and arthralgia.
Hepatomegaly and abnormal liver tests were present in all
patients when ftrst seen. Hepatic enlargement was usu.ally
moderate, but was massive in 2 patients, extending to the nght
iliac fossa in 1. Splenomegaly and ascites were present in 3
pati<:nts. Examination usually revealed flor~d stigma.ta of
chronic liver disease, including numerous spider naevI and
palmar erythema, as well as peripheral oedema. All 8 patients
demonstrated xantholasmas.
Associated diseases in the 8 patients included the sicca
syndrome (3 cases), hypothyroidism (2 cases), renal tubular
acidosis (1 case), seropositive rheumatoid arthritis (1 case) and
seronegative symmetrical arthropathy (1 case). Three patients
have hepatic osteodystrophy. Leg ulceration with panniculitis
was noted in 2 cases.















Liver function tests usually demonstrated cholestasis with
normal or slightly elevated transaminases (Table I). One patient
developed a sudden rise in serum bilirubin levels, deteriorated
rapidly and died within I year (Fig. 3).
Fig. 1. Skin excoriation, scarring and cholesterol deposition in
patient with severe pruritus secondary to PBC.
Fig. 2. Lateral radiograph of lumbar spine revealing osteoporosis
and wedge compression fractures of T12 and>L2, 3 in a patient
with hepatic osteodystrophy and PBC.
Variceal haemorrhage has occurred in only I patient to date.
Two others have chronic ponasystemic encephalopathy. Thus
3 of the 8 cases had evidence of ponal hypenension.
Initial misdiagnosis of this condition has been the rule.
Hepatic tumours, lymphoma, myeloma and extrahepatic biliary _
obstruction had all been considered likely diagnoses before
patients presented at our clinic. This had led to 2 patients
undergoing laparotomy, while others were subjected to peri-
toneoscopy and coeliac angiography.
Years
Fig. 3. Serial serum bilirubin estimations in a patient with PBC.
Note accelerated increase from 1984 to 1985 before death.
All patients demonstrated hypergammaglobulinaemia with
the classic elevation of IgM. Three patients had elevated IgG
levels (Table I) and this appeared to correlate with the pre-
sence of piecemeal necrosis on liver biopsy. Seven patients had
significant and consistent elevation of antimitochondrial
antibodies. Antinuclear factor was detected in 2> patients,
smooth muscle antibodies in 7 patients and rheumatoid factor
(sheep cell agglutination test and latex test) in 2 patients.
Pathology
PBC may be staged histologically as follows: 5•6 stage I
represents the initial lesion with bile duct injury, portal triaditis
and, at times, hepatic granulomata; stage Il is defmed by
periponal inflammation, which progresses to scarring with
fibrous septa in stage Ill; stage IV represents cirrhosis.
Although useful, this staging process is subject to sampling
bias and indeed one biopsy sample may contain areas showing
different stages of evolution.
Liver biopsies in the 8 patients revealed predominantly
stage III and IV disease accompanied by florid ductal lesions
(Figs 4 and 5).
Fig. 4. Medium-sized bile duct with intra-epithelial Iymphocytes
and periductal inflammatory mononuclear cells with early fibrosis.
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TABLE J. RESULTS OF LIVER FUNCTION TESTS AND IMMUNOGLOBULIN VALUES










































Fig. 5. Scarring with periportal inflammation, ductular proliferation
and associated hepatocyte piecemeal necrosis.
Natural history
Despite the delayed diagnosis and presence of advanced
disease the 5-year survival figures are 75%. The rate of progres-
sion of the disease has been higWy variable.
Discussion
In series from elsewhere published before 1960 the diagnosis
was usually made late in the course of the illness, at a time
when jaundice, liver failure and portal hypertension are more
common. NoW) in contrast, the onset of disease is typically
recognised earlier, between the ages of 30 years and 65 years.
This is apparently because of a greater awareness of the
disease and its presenting manifestations.
It is our impression that the patients resemble those
described in the earlier series, rather than more recent series.
This suggests a generally late diagnosis in most instances.
Clinically, PBC progresses through five stages.s The pre-
symptomatic phase is characterised by mild fatigue and menor-
rhagia. Hepatomegaly may be present. The serum alkaline
phosphatase level is always raised. The diagnosis at this point
should be confirmed by liver biopsy, which may reveal mono-
. nuclear cell infiltration confined to the portal tract. Detection
of antimitochondrial antibodies strengthens the diagnosis con-
siderably.
The oligosymptomatic phase, with 'bile regurgitation',
merges into the symptomatic anicteric phase, This is charac-
terised by a disturbance of bile secretion, and pruritus and
fatigue are invariably present.
Eventually ·the clinical picture evolves into the icteric phase.
Bile secretion is severely disturbed. Patients have jaundice
(progressive or stable) with pruritus. Skin pigmentation,
excoriations, xantholasmas and spider paevi are common (Fig.
1). The liver is usually enlarged but splenomegaly is only
noted in about one-third of cases. Steatorrhoea and hepatic
osteodystrophy are common and may cause distressing symp-
toms. 1 The fmal phase is that of hepatocellular failure. Patients
develop symptoms of portal hypertension, and may have en-
cephalopathy and ascites. A number of patients present for the
fust time with such advanced disease. 7
The association of PBC with scleroderma, Sjogren's syn-
drome, arthropathy, hypothyroidism and renal tubular acidosis
is well established. I That PBC is associated with both hepato-
cellularB and breast cancer9 is less well known.
Advanced age, hepatomegaly, an elevated serum bilirubin
level, a decreased serum albumin value and histologically
confirmed cirrhosis are' thought to correlate with shortened
survival. 10 The serum bilirubin level is typically normal in the
early stages of the disease but rises later in most patients: An
~levation in the serum bilirubin value is associated with a poor
prognosis. II Indeed, a rapid rise in the serum bilirubin level,
as we observed in 1 patient, is associated with a marked
clinical deterioration, which may preclude liver transplanta-
tion.
An awareness of the clinical features of PBC and a high
index'of suspicion are important in making the diagnosis. It
must be stressed, however, that an obstruction of the biliary
system must always be excluded before accepting the diagnosis.
Ultrasonography, computer tomography and endoscopic retro-
grade cholangiopancreatography are important in demonstrating
patency of the bile ducts. Percutaneous needle biopsy will
provide confirmatory information and allow histological staging
ofPBC.
There is no satisfactory treatment for the condition. The
pruritus usually responds to cholestyramine, an anion-binding
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resin that binds bile acids in the bowel lumen. Other options
for the treannent of pruritus include histamine-2 receptor
blockers, large-volume plasmapheresis and the administration
of rifampicin. Anention to nutrition is imponant and parenteral
supplements of the fat-soluble vitamins A, D, E and K must
be administered regularly.l
More specific treannents used for this condition are reviewed
by Kaplan et al. 1 These include corticosteroids, azathioprine,
penicillamine, colchicine, chlorambucil, cyclosporin and
ursodeoxycholic acid. Most of our patients received immuno-
suppressive agents, and we have tended in recent years to treat
patie~ts with colchicine (0,5 mg twice a day), which is said to
slow the progression of the disease and has minimai side-
effects. 12 None of these agents is curative and liver transplan-
tation remains the treatment of choice in patients with liver
failure and in those with recurrent oesophageal variceal
haemorrhage. l
Conclusion
PBC is rare in South Mrica. The diagnosis in our patients was
almost always delayed and they" had often been subjected to
unnecessary invasive investigations. Early referral to a liver
centre is essential in order to confirm the diagnosis, to treat
the symptoms, minimise complications and to ensure that liver
transplantation is considered at an appropriate stage of the
disease.
The pattern of childhood
in the western Cape
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Summary
An analysis of poisoning cases treated at the Red Cross War
Memorial Children's Hospital dUring 1987 and of calls received
on the poisons line is presented. Treatment of 1116 children
was undertaken and 922 telephone calls were logged. Of the
patients treated, 60% had ingested a drug and 30% had
drunk paraffin. The high prevalence of paraffin poisoning in
the western Cape is examined. Constant vigilance must be
maintained if childhood poisoning is to be prevented.
S Atr Med J 1990; 78: 22-24.
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A poisons service has been in operation at the Red Cross War
Memorial Children's ·Hospital, Cape Town, for the past 17
years. l,2 It has four components: a Poisons Information Centre,
which collects information and maintains the database; a
Poisons Information Service to which medical personnel and
the general public have 24-hour direct access; a clinical service
provided by the outpatient depanment and wards of the
hospital; and a linked toxicology laboratory service provided
by the Department of Pharmacology at Tygerberg Hospital,
Parowvallei, CP. .
A study was undenaken to document the workload carried
by the Poisons Information Service and the clinical load
handled by the hospital in ·1987.
Materials and methods
Hospital admissions for poisoning
A search was made of admission records for 1987. Cases of.
poisoning were identified by the diagnosis codes of the 9th
edition of the Internalional Classificalion of Diseases entered on
the hospital records computer at the time of discharge against
